Huaren Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 406.7 million compared to CNY 403.24 million a year ago. Net income was CNY 50.82 million compared to CNY 41.1 million a year ago.

Basic earnings per share from continuing operations was CNY 0.043 compared to CNY 0.0348 a year ago. Diluted earnings per share from continuing operations was CNY 0.043 compared to CNY 0.0348 a year ago.